新聞/Reuters/Teva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyTeva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyRefinitiv閱讀少於1分鐘TEVATeva Pharmaceutical Industries Ltd TEVA:TEVA’S EMRUSOLMIN GRANTED U.S. FDA FAST TRACK DESIGNATION FOR TREATMENT OF MULTIPLE SYSTEM ATROPHYReuters以色列股票美國股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
